COMMUNIQUÉS West-GlobeNewswire

Sequana Medical announces results of Annual General Meeting of Shareholders
28/05/2026
Ghent, Belgium, May 28, 2026 (GLOBE NEWSWIRE) -- PRESS RELEASE | REGULATED INFORMATION | 28 May 2026, 9:00 pm CEST Ghent, Belgium – 28 May 2026 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " [...]
Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
28/05/2026
Real-world analysis of three years of closed claims data from Symphony Health, focused on the third year of the study (2023-2024), comprised of more than 261,000 U.S. adults with fibromyalgia Data demonstrate a [...]
Parexel to Present Real-World Oncology Research and Launch New Patient-Focused Campaign at ASCO 2026
28/05/2026
Two virtual posters accepted exploring rejections in oncology marketing applications and real-world pulmonary safety of T-DXd in HER2-positive metastatic breast cancer From Insights to Life campaign reinforces Parexel’s [...]
Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference
28/05/2026
CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that it [...]
Apogee Therapeutics to Participate in Upcoming June Conferences
28/05/2026
SAN FRANCISCO and BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), today announced that members of management will participate at the following investor conferences. Jefferies Global [...]
rYojbaba Rings the Nasdaq Stock Market Opening Bell, Celebrating Its Mission to “Fight Poverty” on the Global Stage
28/05/2026
CEO Ryoji Baba shares the company’s vision of combining the Samurai Spirit with AI and technology to break language barriers and create opportunities for the next generation FUKUOKA, Japan, May 28, 2026 (GLOBE NEWSWIRE [...]
Kane Biotech Announces First Quarter 2026 Financial Results
28/05/2026
WINNIPEG, Manitoba, May 28, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its first quarter 2026 financial results. First Quarter 2026 Financial [...]
Taurus Meds TRT Claims Evaluated: Powerful Testosterone Replacement Therapy & Taurus Charge ED Medication
28/05/2026
Online TRT Blood Work Through LabCorp and Quest Diagnostics, Sublingual 4-in-1 ED Medication, Prescription Access, and Pricing Explained Wilmington, DE, May 28, 2026 (GLOBE NEWSWIRE) -- Compounded medications are not [...]
Repairon annonce la publication dans le NEJM des résultats de l’essai clinique BIOVAT-HF, une thérapie innovante pour l’insuffisance cardiaque avancée
28/05/2026
Repairon annonce la publication dans le New England Journal of Medicine des résultats d’un essai clinique évaluant du tissu musculaire cardiaque humain artificiel GÖTTINGEN, Allemagne et PROVIDENCE, Rhode Island, 28 mai [...]
Outlook Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
28/05/2026
ISELIN, N.J., May 28, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of ONS-5010/LYTENAVA™ (bevacizumab-vikg, bevacizumab [...]
Allogene Therapeutics Announces Planned CEO Succession
28/05/2026
David Chang, M.D., Ph.D., to Transition from President and Chief Executive Officer Following Eight Years of Outstanding Leadership and Continue to Serve on the Board of Directors Zachary Roberts, M.D., Ph.D., EVP, [...]
Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy
28/05/2026
GAITHERSBURG, Md., May 28, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has been awarded a contract modification valued at approximately $64.5 million from the Administration for [...]
New Research from ATI Advisory Finds I-SNP Enrollment Associated with Better Outcomes for Long-Term Care Residents
29/05/2026
ATI Advisory study, supported by AHCA/NCAL, shows correlation between I-SNP enrollment and lower rates of hospitalization, emergency department visits, and mortality among nursing facility residents Washington, DC, May [...]
LB Pharmaceuticals to Participate in Upcoming June Investor Events
28/05/2026
NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar [...]
Medline Inc. announces closing of upsized secondary offering of Class A common stock
28/05/2026
NORTHFIELD, Ill., May 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its upsized secondary offering of 72,554,594 shares of Medline Inc.’s Class A common stock by [...]
Tarsus to Participate in Upcoming Investor Conferences
28/05/2026
IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences: William Blair 46 th [...]
Fortis Life Sciences enrichit son portefeuille AbNano® avec la première bibliothèque VHH dérivée de cellules tueuses naturelles périphériques pour accélérer la découverte d’anticorps
28/05/2026
La nouvelle bibliothèque AbNano® facilite la découverte de VHH dirigés contre des cibles complexes associées aux cellules NK, au service des plateformes de cellules modifiées et de la recherche translationnelle BOSTON, [...]
Assembly Biosciences Announces Upcoming Investor Conference Presentations
28/05/2026
SOUTH SAN FRANCISCO, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today [...]
Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
28/05/2026
RESEARCH TRIANGLE PARK, N.C., May 28, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients [...]

Pages